{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027201","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2026-06-04T12:00:40+00:00","discovered_at":"2026-06-04T12:05:00.305210+00:00","generated_at":"2026-06-04T12:06:34.218565+00:00","sec_items":["1.01","2.03","3.02","5.03","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"IMUNON secures up to $10M through preferred stock and secured notes for Phase 3 trial","bullets":["Gross proceeds of $10M from 250 Series A Preferred shares ($2.5M) and secured promissory notes ($7.72M total).","Notes mature in 18 months; A-1 Note at 8% interest, B Note at 5%; secured by assets except IP.","$5M placed in cash collateral; remaining $5M for general corporate purposes including Phase 3 OVATION 3 trial.","Preferred stock is non-convertible, non-voting, 8% annual return; redeemable at 110% of liquidation amount.","Financing structured as non-dilutive with no warrants; management highlights shareholder-friendly terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027201","json":"https://secwatch.observer/filing/0001493152-26-027201.json","markdown":"https://secwatch.observer/filing/0001493152-26-027201.md","text":"https://secwatch.observer/filing/0001493152-26-027201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T12:06:34.218565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f52e7d33a1cf971cf3e85ff26e2154ee60503dc","claim":"Imunon, Inc. incurred debt of $5,000,000 with Streeterville Capital, LLC at 5% per annum maturing 18 months following the Closing Date.","evidence_excerpt":"(ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”). The transactions contemplated by the Securities Purchase Agreement (collectively, the “ Transaction ”) closed on","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Principal","value":"$5,000,000"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Rate","value":"5% per annum"},{"label":"Maturity","value":"18 months following the Closing Date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"88d4952ff7d77a87b05533508fa1b426de092a0e","claim":"Imunon, Inc. incurred debt of $2,720,000 with Streeterville Capital, LLC at 8% per annum maturing 18 months following the Closing Date.","evidence_excerpt":"(the “ Series A Preferred Stock ”), at a price of $10,000 per share, for aggregate proceeds of $2,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”). The","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Principal","value":"$2,720,000"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"18 months following the Closing Date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"59723d2ee4f5fc8b1e9eb85bf94b52e61c8e9d20","claim":"Imunon, Inc.: Filed a Certificate of Designation for Series A Preferred Stock designating 400 shares (effective 2026-06-01).","evidence_excerpt":"On June 1, 2026, the Company filed a certificate of designation of preferences and rights (the “ Certificate of Designation ”) of the Series A Preferred Stock with the Secretary of State of the State of Delaware, designating 400 shares of Series A Preferred Stock, which became effective upon filing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-06-01"}],"fact_type":"governance_change"},{"claim_id":"af5b1008739b1c5f48db29487de480e66c7a15ed","claim":"Imunon, Inc. entered into Securities Purchase Agreement with Streeterville Capital, LLC valued at Total financing of $10,000,000; issuance of 250 shares of Series A Preferred Stock at $10,000 per sh (effective 2026-06-02).","evidence_excerpt":"On June 2, 2026, Imunon, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Streeterville Capital, LLC (the “ Investor ”), providing for the issuance and sale by the Company, and the purchase by the Investor, of (i) 250 shares (the “ Preferred Shares ”) of the Company’s Series A Preferred Stock, par value $0.01 per share (the “ Series A Preferred Stock ”), at a price of $10,000 per share, for aggregate proceeds of $2,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Value","value":"Total financing of $10,000,000; issuance of 250 shares of Series A Preferred Stock at $10,000 per sh"},{"label":"Effective","value":"2026-06-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}